Bookmark! (press Ctrl+D)

We kick off the fall series of UCSF Covid Medical Grand Rounds with a wide-ranging program on epidemiology and therapeutics. George Rutherford will discuss the current state of the pandemic, including the falling infection rates in the South and West, and the growing rates in the Midwest, schools, and universities. Monica Gandhi will discuss why Covid mortality rates seem to be falling, including the possibility (as discussed in her recent New England Journal of Medicine paper that mask wearing leads to less severe infections). Finally, Aashish Manglik will describe the discovery made by him and his UCSF colleagues that inhalable molecules (“AeroNabs”) can block the receptors that allow the coronavirus to gain entry to the human upper respiratory tract. The session is moderated by UCSF Department of Medicine chair Bob Wachter.

Program
Bob Wachter: Introduction
00:04:22 Current State of the Pandemic: George Rutherford, Professor, Dept. of Epidemiology & Biostatistics; Director of the Prevention and Public Health Group
00:30:11 Q&A for Dr. Rutherford
00:32:21 Covid’s Mortality Rate: Monica Gandhi, Professor of Medicine; Associate Chief of Division of HIV, Infectious Diseases, and Global Medicine at ZSFG; Director of the UCSF-Gladstone Center for AIDS Research; and Medical Director of the HIV Clinic, Ward 86, ZSFG
00:52:04 – Q&A for Drs. Rutherford and Gandhi
01:01:36 – AeroNabs: Aashish Manglik, Assistant Professor, Dept. of Pharmaceutical Chemistry
01:15:07 – Q&A for Dr. Manglik
1:26:00 – Bob Wachter: Closing

See previous Covid-19 Medical Grand Rounds:
• August 13: New Approaches to Covid-19: Rapid Testing, Herd Immunity, and the Role of Narrative

• August 6: A Conversation with Ashish Jha

• July 30: An Update on Covid-19 Testing, Treatments, and Vaccines

• July 23: Covid-19: Reports of New Surges from Miami, Atlanta, Houston, and UCSF

See all UCSF Covid-19 grand rounds, which have been viewed nearly 900,000 times, here: https://medicine.ucsf.edu/covid-19-news-coverage

source

LEAVE A REPLY

Please enter your comment!
Please enter your name here